The world’s giant pharmaceutical companies are always a popular target of many special interest groups, political operatives, and people opposed to capitalism.
The drug companies do make big profits, but also have high expenses due to research and development costs, labor costs, and lawsuits.
And unlike giant retailers who can simply hire low-skill, low-education workers at low wages to restock store shelves, pharmaceutical companies have to pay outstanding salaries to a highly-educated worker, and compete with other drug companies for the services of those workers.
One of those drug companies, Pfizer, is rolling out a Covid-19 booster vaccine, that will boost its profits too.
Pfizer’s top science officer, Mikael Dolsten, says people at the greatest risk will be first in line to get COVID-19 booster shots.
Pfizer people who have been vaccinated with the first 2 vaccines, will need a third dose within 12 months of being fully vaccinated.
The shots will likely be needed annually.
Mikael Dolsten said it makes sense for older Americans who have underlying conditions to be the first to get the booster shots.
Pfizer says it expects to make 26-billion dollars this year…just from the sale of its COVID-19 vaccine.
Photo of a syringe with a dollar bill rolled up inside the area where the vaccine serum would be.
Photo from Alpha Media USA Portland OR